Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DVN vs GSK✓SelectedUSD · GSKDVN vs GSK performance historyLatest closeAs of+0.21%11/19
Stock and ETF performance explorer

DVN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,020.0%
GSK return
+1,646.5%
Excess return
-626.5%
Maximum drawdown
-94.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-1.6%+1.8%+0.6%
7D-9.0%-4.7%-4.3%-7.8%
30D-16.5%-4.7%-11.8%-15.6%
3M-12.2%-8.8%-3.4%-10.4%
6M-14.2%-4.6%-9.6%-13.8%
YTD+17.0%+1.0%+16.0%+14.9%
1Y+22.2%+6.9%+15.4%+18.1%
3Y+2.3%+52.5%-50.3%-12.7%
5Y+31.2%+40.3%-9.1%+13.6%
10Y+38.7%+99.0%-60.3%+8.4%
All+1,020.0%+1,646.5%-626.5%+536.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling